You just read:

InCarda Therapeutics Initiates Enrollment of Phase 1 Clinical Trial of Inhaled Flecainide for the Treatment of Cardiac Arrhythmias

News provided by

InCarda Therapeutics

Aug 31, 2016, 09:00 ET